Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial.

Eur J Heart Fail · 2013 · PMC3806282 · PMID 23787722

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a weak trendP = 0not a probability at all

In patients with anaemia, FCM therapy was followed by significantly lower rates of death due to worsening HF ( P = 0.013) and hospitalization for any cardiovascular reason ( P = 0.026) compared with placebo, and there was also a weak trend towards a lower rate of hospitalization for any cardiovascular reason or death ( P = 0.·094).

also in 1,404 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.